The Effects of Pemafibrate in Japanese Patients with Type 2 Diabetes Receiving HMG-CoA Reductase Inhibitors

Post time 2022-2-23 02:34:35

journal：Endocrine, Metabolic & Immune Disorders - Drug Targets

Authors：Masataka Kusunoki; Takahiko Sakazaki; Kazuhiko Tsutsumi; Tetsuro Miyata; Yoshiharu Oshida

Published date：2021-5-6

DOI：10.2174/1871530320999200818135553

Article link：http://dx.doi.org/10.2174/1871530320999200818135553

Article Source：Bentham Science Publishers Ltd.。

Remark：

Post time 2022-2-23 02:34:36

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Bentham] The Effects of Pemafibrate in Japanese Patients with Type 2 Diabetes Receiving HMG-CoA Reductase Inhibitors

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Bentham] The Effects of Pemafibrate in Japanese Patients with Type 2 Diabetes Receiving HMG-CoA Reductase Inhibitors Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Bentham] The Effects of Pemafibrate in Japanese Patients with Type 2 Diabetes Receiving HMG-CoA Reductase Inhibitors